Veco Medical Science and Technology Association was established

Time:

2024-01-10

 

 
 

On January 9, the founding meeting of the Science and Technology Association of Wuhan Vickor Medical Technology Co., Ltd. (hereinafter referred to as "Vickor Medical") was successfully held, which is also the first new enterprise science and technology association organization in Wuhan in 2024. Liu Zhiwu, Vice chairman of the Municipal Science and Technology Association, Zeng Bo, head of the enterprise Department of the Municipal Science and Technology Association, Wu Shiying, second-level researcher of the Science and Technology Innovation Bureau of East Lake High-tech Zone, Wang Xueli, general manager of Weike Medical, and Chen Song, deputy general manager, attended the meeting.

Wang Xueli gave a welcome speech on behalf of the company and introduced the basic situation of the company, Zeng Bo read the approval document of the company's Science and Technology association, the assembly reviewed and passed the "Company's science and Technology Association Constitution", and elected the first leadership of the company's science and Technology Association.

 
 

Chen Song was elected as the first chairman of the Association for Science and Technology of the company, Wang Xueli was elected as the vice chairman of the Association, and Sun Ming, deputy director of research and development, was elected as the secretary-general of the Association. Chen Song said in his speech that the establishment of the Association for Science and Technology will better promote scientific and technological innovation within the company, strengthen cross-field technical exchanges, and further enhance the company's research and development capabilities and market competitiveness.

Wu Shiying congratulated the establishment of Weike Medical Science Association, she hoped that after the establishment of the enterprise Science and Technology Association, the normal organization to carry out science and technology association activities, strengthen the humanistic care for science and technology workers, innovation and creation around the professional field, solve the "neck" technical problems, cultivate the internal power of innovation and development, and walk out of the road of characteristic development.

Liu Zhiwu said that the establishment of Weike Medical Science Cooperation organization is a new starting point for the company's innovation and development, and I hope that the enterprise Science and Technology Association will adhere to the service of science and technology workers and play a good role as a bridge; Insist that talent is the first resource, attach importance to the training of enterprise scientific and technological personnel, and promote the growth and improvement of scientific and technological workers; We should keep innovation as the primary driving force, pool external innovation resources, deepen industry-university-research cooperation and exchanges, and promote innovation and development of enterprises. Integrate enterprise and social resources, and actively carry out science popularization.

 

Founded in July 2018, Wuhan Vickor Medical Technology Co., Ltd. focuses on major clinical needs in the cardiovascular field, especially in the field of minimally invasive intervention for heart failure and structural heart disease.

The company is headquartered in Wuhan East Lake High-tech Zone, and in Suzhou, Beijing, Shanghai and other places to lay out the industrial chain upstream and downstream. The founder and scientific research team are composed of interventional experts in structural heart disease, cardiac surgery experts, metal materials experts, braided instruments R & D experts, and medical device registration experts, forming a strong combination of medical research and enterprise.

The company's products cover a wide range of fields, including heart failure prevention related atrial shunt, cardiac stroke prevention related to patent foramen ovale occluder, valve disease treatment related to the transcatheter aortic valve replacement system and related surgical accessories consumables. It has applied for more than 60 patents, including more than 50 invention patents, 10 utility model patents, 3 PCT patents, and related products have complete independent intellectual property rights. The atrial shunt was awarded the NMPA "Innovative Medical Device Special Review Program" and the FDA "Breakthrough Medical Device Designation".